Trivage Tablets x 30
$167.89
Trivage Tablets contain a combination of three active ingredients: Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate. These medications are commonly used in the treatment of HIV infection. Efavirenz is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that helps to inhibit the replication of the virus. Emtricitabine and Tenofovir Disoproxil Fumarate are both nucleoside reverse transcriptase inhibitors (NRTIs) that work by blocking the reverse transcriptase enzyme, thus preventing the virus from replicating and spreading. Together, these three components provide a potent combination therapy for managing HIV infection and improving the patient’s quality of life.
Trivage Tablets is a medication used in the treatment of HIV-1 infection. Each tablet contains a combination of three active ingredients: Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate. These three drugs work together to suppress the replication of the HIV virus and slow down the progression of the disease.
Dosage and Administration:
The recommended dosage of Trivage Tablets is one tablet taken orally once a day, preferably at bedtime, on an empty stomach. It is important to follow your doctor’s instructions regarding the dosage and duration of treatment.
It is essential to take Trivage Tablets consistently and at the same time each day to maintain adequate drug levels in your body. Skipping doses or discontinuing treatment without consulting your doctor can lead to reduced effectiveness and the development of drug resistance.
Before starting Trivage Tablets, your healthcare provider will perform tests to assess your kidney function and check for any potential drug interactions with other medications you may be taking.
Possible Side Effects:
Like any medication, Trivage Tablets may cause side effects. The most common side effects associated with this medication include dizziness, headache, trouble sleeping, abnormal dreams, fatigue, nausea, diarrhea, rash, and depression. These side effects are usually mild and tend to improve or disappear over time.
However, some individuals may experience more serious side effects, such as severe skin reactions, liver problems, kidney problems, or psychiatric symptoms. If you experience any unusual or severe side effects, it is crucial to contact your healthcare provider immediately.
Precautions:
Before taking Trivage Tablets, inform your doctor about any existing medical conditions you have, especially liver or kidney disease, mental health disorders, or a history of drug or alcohol abuse. It is also important to disclose all other medications, including over-the-counter drugs and herbal supplements, as they may interact with Trivage Tablets.
Trivage Tablets may cause dizziness, drowsiness, or trouble concentrating. It is advisable to avoid driving or operating machinery until you know how the medication affects you.
Additionally, Trivage Tablets is not recommended during pregnancy, as it may cause harm to the developing fetus. If you are planning to become pregnant or suspect that you may be pregnant, discuss the risks and benefits of this medication with your healthcare provider.
In conclusion, Trivage Tablets is a combination medication used in the treatment of HIV-1 infection. It contains Efavirenz, Emtricitabine, and Tenofovir Disoproxil Fumarate. The recommended dosage is one tablet taken orally once a day on an empty stomach. It is important to take the medication consistently and at the same time each day. Common side effects include dizziness, headache, trouble sleeping, and nausea. Serious side effects and interactions with other medications should be discussed with your healthcare provider.
| Weight | 0.06 kg |
|---|---|
| Dimensions | 3 × 3 × 1 cm |
Related products
